Calendar
November 2010 December 2010 January 2011
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31
There are no upcoming events currently scheduled.
View full calendar
"Johnson & Johnson's Recall of Children's Tylenol and other Pediatric Medicines" PDF Print

On Thursday, May 26, 2010, the House Committee on Oversight and Government Reform held a hearing entitled, “Johnson and Johnson’s Recall of Children’s Tylenol and Other Children’s Medicines.” The hearing examined the circumstances surrounding the voluntary recall of popular infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare.

On May 5, 2010, Chairman Towns and Ranking Member Darrell Issa (R-CA) opened the committee’s investigation into the circumstances surrounding the voluntary recall of widely used pediatric medications.Johnson & Johnson recalled 6 million bottles from over 40 different types of medicines including brands such as Children’s Tylenol, Infants’ Tylenol, Children’s Motrin, and Children’s Benadryl.

To watch a webcast of the hearing, click here

The hearing took place at 10:00 a.m. in room 2154 Rayburn House Office Building. The witnesses scheduled to testify included:

Panel I

Dr. Joshua M. Sharfstein
Principal Deputy Commissioner
U.S. Food & Drug Administration

Accompanied by:

Ms. Deborah M. Autor
Director of the Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration; and

Mr. Michael A. Chappell
Acting Associate Commissioner for Regulatory Affairs
Food and Drug Administration

Panel II

Ms. Colleen Goggins
Worldwide Chairman
Johnson & Johnson Consumer Group

Documents and Links

Opening Statement of Chairman Edolphus Towns

Prepared testimony of Dr. Joshua Sharfstein

Prepared testimony of Ms. Colleen Goggins

Closing Statement of Chairman Edolphus Towns

FDA Documents

CSCS Motrin Purchase Project Document

 

Committee On Oversight and Government Reform

U.S. House of Representatives | 2157 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051